TotalMarketCap

Attovia Therapeutics

ATTONasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$684.084 M

$14.99 -3.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Attovia Therapeutics (ATTO) has a market capitalization of $684.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

45,651,262

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #52Sana BiotechnologySANA$697.5M
  2. #53Solid BiosciencesSLDB$686.4M
  3. #54Attovia TherapeuticsATTO$684.1M
  4. #55Aura BiosciencesAURA$659.6M
  5. #56Ginkgo BioworksDNA$646.9M

What if Attovia Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$618,534.35

Per share 41,277× higher

Bitcoin $1.53T

$33,467.82

Per share 2,233× higher

Apple $5.02T

$109,871.72

Per share 7,332× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Attovia Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.